A Novel Preclinical Murine Model to Monitor Inflammatory Breast Cancer Tumor Growth and Lymphovascular Invasion
… cancer, is often misdiagnosed due to its unique presentation … Various breast cancer cells
stably transfected to express … vessel characteristics can be expanded to investigate other cancer …
stably transfected to express … vessel characteristics can be expanded to investigate other cancer …
Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer
H Li, G Song, Q Zhou, R Ran, H Jiang, R Zhang… - Breast Cancer Research …, 2021 - Springer
… evaluated in AR expression breast cancer cells and in breast cancer xenograft model. A 3
+ 3 phase I dose-escalation study was launched in Peking University Cancer Hospital. The …
+ 3 phase I dose-escalation study was launched in Peking University Cancer Hospital. The …
Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation
O Lee, D Ivancic, S Allu, A Shidfar, K Kenney… - Cancer chemotherapy …, 2015 - Springer
… by women at high risk of breast cancer has been low. Reasons … , breast cancer prevention
requires only that the breast be … The participant characteristics were similar between groups (…
requires only that the breast be … The participant characteristics were similar between groups (…
Recombinant human erythropoietin in combination with chemotherapy increases breast cancer metastasis in preclinical mouse models
… However, minimal preclinical data are available about the … human breast cancer cells using
in vitro assays and preclinical … Effect of rHuEPO on in vitro growth characteristics of MDA-MB-…
in vitro assays and preclinical … Effect of rHuEPO on in vitro growth characteristics of MDA-MB-…
Patient-derived xenograft models of breast cancer and their predictive power
… PDX models have been shown to retain the principal molecular characteristics of the … PDX
models for the preclinical testing of immunotherapies in breast cancer. Rather, syngeneic mice …
models for the preclinical testing of immunotherapies in breast cancer. Rather, syngeneic mice …
Preclinical and clinical studies of interferons and interferon inducers in breast cancer
EC Borden, FR Balkwill - Cancer, 1984 - Wiley Online Library
… Preclinical and clinical studies suggest interferons and interferon inducers have antitumor
activity for breast … of freshly derived and continuously passaged breast carcinoma cells in vitro, …
activity for breast … of freshly derived and continuously passaged breast carcinoma cells in vitro, …
Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer
… We performed Agena MassArray analysis of 227 HER2+ breast cancer samples to identify
the … mutant, ER positive) HER2+ breast cancer cell lines for functional in vitro experiments. …
the … mutant, ER positive) HER2+ breast cancer cell lines for functional in vitro experiments. …
Discovery and validation of breast cancer early detection biomarkers in preclinical samples
CI Li - Hormones and Cancer, 2011 - Springer
… Cases and controls were ascertained from the WHI OS, and the characteristics of cases
and controls in our discovery and independent validation sets are shown in Table 1. Controls …
and controls in our discovery and independent validation sets are shown in Table 1. Controls …
Orthotopic transplantation of breast tumors as preclinical models for breast cancer
… Preclinical models that faithfully recapitulate tumor heterogeneity and therapeutic response
are critical for translational breast cancer research. Immortalized cell lines are easy to grow …
are critical for translational breast cancer research. Immortalized cell lines are easy to grow …
In vivo models in breast cancer research: progress, challenges and future directions
… varied uses of these models in breast cancer research, their strengths, … breast cancer; what
are the appropriate models of metastatic disease; can we use models to carry out preclinical …
are the appropriate models of metastatic disease; can we use models to carry out preclinical …